Literature DB >> 9573239

Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.

T J Wrona1, M Lozano, A A Binhazim, J P Dudley.   

Abstract

The mouse mammary tumor virus (MMTV) encodes within the U3 region of the long terminal repeat (LTR) a protein known as the superantigen (Sag). Sag is needed for the efficient transmission of milk-borne virus from the gut to target tissue in the mammary gland. MMTV-infected B cells in the gut express Sag as a type II transmembrane protein that is recognized by the variable region of particular beta chains (Vbeta) of the T-cell receptor (TCR) on the surface of T cells. Recognition of Sag by particular TCRs results in T-cell stimulation, release of cytokines, and amplification of MMTV infection in lymphoid cells that are needed for infection of adolescent mammary tissue. Because the C-terminal 30 to 40 amino acids of Sag are variable and correlate with recognition of particular TCR Vbeta chains, we prepared a series of C-terminal Sag mutations that were introduced into a cloned infectious MMTV provirus. Virus-producing XC rat cells were used for injection of susceptible BALB/c mice, and these mice were monitored for functional Sag activity by the deletion of C3H MMTV Sag-reactive (CD4+ Vbeta14+) T cells. Injected mice also were analyzed for mutant infection and tumor formation in mammary glands as well as milk-borne transmission of MMTV to offspring. Most mutations abrogated Sag function, although one mutation (HPA242) that changed the negative charge of the extreme C terminus to a positive charge created a weaker Sag that slowed the kinetics of Sag-mediated T-cell deletion. Despite the lack of Sag activity, many of the sag mutant viruses were capable of sporadic infections of the mammary glands of injected mice but not of offspring mice, indicating that functional Sag increases the probability of milk-borne MMTV infection. Furthermore, although most viruses encoding nonfunctional Sags were unable to cause mammary tumors, tumors were induced by such viruses carrying mutations in a negative regulatory element that overlaps the sag gene within the LTR, suggesting that loss of Sag function may be compensated, at least partially, by loss of transcriptional suppression in certain tissues. Together these results confirm the importance of Sag for efficient milk-borne transmission and indicate that the entire C-terminal region is needed for complete Sag function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573239      PMCID: PMC110007          DOI: 10.1128/JVI.72.6.4746-4755.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression.

Authors:  J Liu; D Bramblett; Q Zhu; M Lozano; R Kobayashi; S R Ross; J P Dudley
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  New superantigen specificity created by two amino acid replacements.

Authors:  O A Rosenwasser; S Fairchild; K Tomonari
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission.

Authors:  W Held; G A Waanders; A N Shakhov; L Scarpellino; H Acha-Orbea; H R MacDonald
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

4.  Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.

Authors:  W H Günzburg; F Heinemann; S Wintersperger; T Miethke; H Wagner; V Erfle; B Salmons
Journal:  Nature       Date:  1993-07-08       Impact factor: 49.962

5.  A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor.

Authors:  S Mink; E Härtig; P Jennewein; W Doppler; A C Cato
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

6.  Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins.

Authors:  C Brandt-Carlson; J S Butel; D Wheeler
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

7.  Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.

Authors:  G M Shackleford; C A MacArthur; H C Kwan; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

8.  Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas.

Authors:  S Yanagawa; K Kakimi; H Tanaka; A Murakami; Y Nakagawa; Y Kubo; Y Yamada; H Hiai; K Kuribayashi; T Masuda
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.

Authors:  G A Waanders; A N Shakhov; W Held; O Karapetian; H Acha-Orbea; H R MacDonald
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

10.  Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor V beta specificity.

Authors:  K Yazdanbakhsh; C G Park; G M Winslow; Y Choi
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  14 in total

1.  The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas.

Authors:  L Rajan; D Broussard; M Lozano; C G Lee; C A Kozak; J P Dudley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.

Authors:  F Baribaud; S Wirth; I Maillard; S Valsesia; H Acha-Orbea; H Diggelmann
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.

Authors:  A Barnett; F Mustafa; T J Wrona; M Lozano; J P Dudley
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Conversion of mouse mammary tumor virus to a lymphomagenic virus.

Authors:  Sanchita Bhadra; Mary M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene.

Authors:  F Mustafa; M Lozano; J P Dudley
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Selection for c-myc integration sites in polyclonal T-cell lymphomas.

Authors:  Dana R Broussard; Jennifer A Mertz; M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  The homeodomain protein CDP regulates mammary-specific gene transcription and tumorigenesis.

Authors:  Quan Zhu; Urmila Maitra; Dennis Johnston; Mary Lozano; Jaquelin P Dudley
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

8.  A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice.

Authors:  Chioma M Okeoma; Ming Shen; Susan R Ross
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

9.  Infection of cells of human embryonal kidneys by mouse mammary tumor virus (MMTV).

Authors:  A A Lushnikova; I N Krukova; L N Lyubchenko; A A Parokonnaya
Journal:  Dokl Biol Sci       Date:  2009 Jan-Feb

10.  RIII/Sa mice with a high incidence of mammary tumors express two exogenous strains and one potential endogenous strain of mouse mammary tumor virus.

Authors:  Nurul H Sarkar; Tatyana Golovkina; Taher Uz-Zaman
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.